Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Coca-Cola Company (A): The Rise and Fall of M. Douglas Ivester (Abridged)
Watkins, Michael D.; Knoop, Carin-Isabel; Reavis, CateCaso HBS-808074-EThis is a shortened version of The Coca-Cola Company (A): The Rise and Fall of M. Douglas Ivester, HBS case #9-800-355. It eliminates some background detail and the financial data and exhibits. As with the original case, it chronicles the appointment of Douglas Ivester as CEO of Coca-Cola and the missteps that led to his dismissal.Desde 8,20 €
-
ATH Technologies (E)
Simons, Robert L.; Packard, JenniferCaso HBS-117017-EDirección estratégicaSupplements the (A) case. Designed as an in-class handout.Desde 5,74 €
-
Merck: Managing Vioxx (E)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCaso HBS-109084-EDesde 5,74 €
-
ATH Technologies (E) (Spanish version)
Simons, Robert L.; Packard, JenniferCaso HBS-118S07Dirección estratégicaSupplements the (A) case. Designed as an in-class handout.Desde 5,74 €
-
Merck: La administración de Vioxx (E)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCaso HBS-111S06Conocimiento y comunicaciónDesde 5,74 €
-
Starbucks and Conservation International (Spanish version)
Austin, James E.; Reavis, CateCaso HBS-309S01Ética empresarial y Responsabilidad Social CorporativaThis case is accompanied by a Video Short that can be shown in class or included in a digital coursepack. Instructors should consider the timing of making the video available to students, as it may reveal key case details. Starbucks, the world's leading specialty coffee company, developed a strategic alliance with Conservation International, a major international environmental nonprofit organization. The purpose of the alliance was to promote cof...Desde 8,20 €
-
Novartis Pharma: Modelo de la Unidad de Negocio
Datar, Srikant M.; Knoop, Carin-Isabel; Reavis, CateCaso HBS-110S30Contabilidad y controlEn junio de 2000, Novartis reorganizó su negocio farmacéutico para formar unidades de negocio globales en oncología, trasplante, oftalmología, y madurar productos. Los productos de cuidado primario restantes continuaron siendo administrado dentro de las funciones globales (por ejemplo, I + D y comercialización). La nueva organización creó una estructura de matriz y las nuevas funciones y responsabilidades de los jefes de las funciones de negocio,...Desde 8,20 €
-
Managing Risk in the New World
Kaplan, Robert S.; Mikes, Anette; Simons, Robert L.; Tufano, Peter; Hofmann, Michael; Champion, DavidArtículo HBS-R0910E-EFive experts gathered recently to discuss the future of enterprise risk management: Kaplan, the Baker Foundation Professor at Harvard Business School, who with his colleague David Norton developed the balanced scorecard; Mikes, an assistant professor at HBS who studies the evolution of risk management and the role of the chief risk officer; Simons, the Charles M. Williams Professor of Business Administration at HBS; Tufano, the Sylvan C . Coleman...Desde 8,20 €
-
C3.ai-Driven to Succeed
Simons, Robert L.; Gonzalez, GeorgeCaso HBS-119004-EDirección estratégicaCEO Tom Siebel navigates his artificial intelligence (ai) startup through a series of pivots, market expansions, and even an elephant attack to become a leading platform ad service provider. The case describes his unusual management approach emphasizing eDesde 8,20 €
-
Managing Vioxx (A) (Spanish version)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCaso HBS-111S02Dirección estratégica(B) evidence of life-threatening side effects, (C) decision options, (D) announcement to withdraw Vioxx, (E) reaction by patients, shareholders, media, and regulators, (F) Merck fights back, and (G) wrap-up. At the end of the case series, students may conclude that doing the right thing sometimes requires very hard choices.Desde 8,20 €